| Anas Entabi M.d., Inc | |
|
38925 Trade Center Drive Suite H Palmdale CA 93551-3655 | |
| (661) 274-9900 | |
| (661) 274-8900 |
| Full Name | Anas Entabi M.d., Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 38925 Trade Center Drive, Palmdale, California |
| Authorized Official Name and Position | Anas Entabi (OWNER/PROVIDER) |
| Authorized Official Contact | 6612749900 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Anas Entabi M.d., Inc 38925 Trade Center Drive Suite H Palmdale CA 93551-3655 Ph: (661) 274-9900 | Anas Entabi M.d., Inc 38925 Trade Center Drive Suite H Palmdale CA 93551-3655 Ph: (661) 274-9900 |
| NPI Number | 1457709321 |
|---|---|
| Provider Enumeration Date | 06/01/2016 |
| Last Update Date | 06/01/2016 |
| Medicare PECOS PAC ID | 7012208093 |
|---|---|
| Medicare Enrollment ID | O20160622001077 |
News Archive
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
Nitric oxide, a gaseous molecule produced in the brain, can damage neurons. When the brain produces too much nitric oxide, it contributes to the severity and progression of stroke and neurodegenerative diseases such as Alzheimer's. Researchers at Sanford-Burnham Medical Research Institute recently discovered that nitric oxide not only damages neurons, it also shuts down the brain's repair mechanisms.
An anti-cancer drug used extensively in chemotherapy binds pervasively to RNA - up to 20-fold more than it does to DNA, a surprise finding that suggests new targeting approaches might be useful, according to University of Oregon researchers.
Researchers have called for a national database to be set up to identify major complications arising from epidural pain relief after a small number of serious problems were identified during a six-year UK study, according to the April issue of Anaesthesia.
GE announced today fourth-quarter 2011 Operating Earnings of $4.1 billion, or $0.39 per share, up 6% and 11% respectively from the fourth-quarter of 2010. Revenues were $38.0 billion for the quarter and $147.3 billion for the year. Record Infrastructure orders of $28.6 billion in the fourth quarter enabled GE to end the year with a backlog of $200 billion, the largest in its history.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457709321 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A94489 (California) | Secondary |
| 207R00000X | Internal Medicine | A89044 (California) | Primary |
| Provider Name | Anas Entabi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1669465258 PECOS PAC ID: 4082653712 Enrollment ID: I20050912000225 |
News Archive
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
Nitric oxide, a gaseous molecule produced in the brain, can damage neurons. When the brain produces too much nitric oxide, it contributes to the severity and progression of stroke and neurodegenerative diseases such as Alzheimer's. Researchers at Sanford-Burnham Medical Research Institute recently discovered that nitric oxide not only damages neurons, it also shuts down the brain's repair mechanisms.
An anti-cancer drug used extensively in chemotherapy binds pervasively to RNA - up to 20-fold more than it does to DNA, a surprise finding that suggests new targeting approaches might be useful, according to University of Oregon researchers.
Researchers have called for a national database to be set up to identify major complications arising from epidural pain relief after a small number of serious problems were identified during a six-year UK study, according to the April issue of Anaesthesia.
GE announced today fourth-quarter 2011 Operating Earnings of $4.1 billion, or $0.39 per share, up 6% and 11% respectively from the fourth-quarter of 2010. Revenues were $38.0 billion for the quarter and $147.3 billion for the year. Record Infrastructure orders of $28.6 billion in the fourth quarter enabled GE to end the year with a backlog of $200 billion, the largest in its history.
› Verified 4 days ago
| Provider Name | Rosa M Gomez |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1801919220 PECOS PAC ID: 8426141672 Enrollment ID: I20070905000265 |
News Archive
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
Nitric oxide, a gaseous molecule produced in the brain, can damage neurons. When the brain produces too much nitric oxide, it contributes to the severity and progression of stroke and neurodegenerative diseases such as Alzheimer's. Researchers at Sanford-Burnham Medical Research Institute recently discovered that nitric oxide not only damages neurons, it also shuts down the brain's repair mechanisms.
An anti-cancer drug used extensively in chemotherapy binds pervasively to RNA - up to 20-fold more than it does to DNA, a surprise finding that suggests new targeting approaches might be useful, according to University of Oregon researchers.
Researchers have called for a national database to be set up to identify major complications arising from epidural pain relief after a small number of serious problems were identified during a six-year UK study, according to the April issue of Anaesthesia.
GE announced today fourth-quarter 2011 Operating Earnings of $4.1 billion, or $0.39 per share, up 6% and 11% respectively from the fourth-quarter of 2010. Revenues were $38.0 billion for the quarter and $147.3 billion for the year. Record Infrastructure orders of $28.6 billion in the fourth quarter enabled GE to end the year with a backlog of $200 billion, the largest in its history.
› Verified 4 days ago
News Archive
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
Nitric oxide, a gaseous molecule produced in the brain, can damage neurons. When the brain produces too much nitric oxide, it contributes to the severity and progression of stroke and neurodegenerative diseases such as Alzheimer's. Researchers at Sanford-Burnham Medical Research Institute recently discovered that nitric oxide not only damages neurons, it also shuts down the brain's repair mechanisms.
An anti-cancer drug used extensively in chemotherapy binds pervasively to RNA - up to 20-fold more than it does to DNA, a surprise finding that suggests new targeting approaches might be useful, according to University of Oregon researchers.
Researchers have called for a national database to be set up to identify major complications arising from epidural pain relief after a small number of serious problems were identified during a six-year UK study, according to the April issue of Anaesthesia.
GE announced today fourth-quarter 2011 Operating Earnings of $4.1 billion, or $0.39 per share, up 6% and 11% respectively from the fourth-quarter of 2010. Revenues were $38.0 billion for the quarter and $147.3 billion for the year. Record Infrastructure orders of $28.6 billion in the fourth quarter enabled GE to end the year with a backlog of $200 billion, the largest in its history.
› Verified 4 days ago
Inpatient Services Of California Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 38600 Medical Center Dr, Palmdale, CA 93551 Phone: 661-382-5000 | |
South Valley Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 38350 40th St E, Palmdale, CA 93552 Phone: 661-272-5001 | |
Independence Community Treatment Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 190 Sierra Ct, Suite C-8, Palmdale, CA 93550 Phone: 818-776-1755 | |
Garrison Family Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 41210 11th St W Ste C, Palmdale, CA 93551 Phone: 661-947-7100 Fax: 661-947-5151 | |
Prime Source Testing Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 190 Sierra Ct Ste 327, Palmdale, CA 93550 Phone: 337-781-5038 | |
Nikta Chiropractic, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1020 E Palmdale Blvd, Suite 101c, Palmdale, CA 93550 Phone: 661-266-1611 Fax: 661-266-1295 | |
Lake Los Angeles Community Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 16921 E Avenue O Ste G, Palmdale, CA 93591 Phone: 661-945-8444 |